Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Seattle Children's Hospital
Children's Oncology Group
Children's Oncology Group
Cellectar Biosciences, Inc.
University of California, San Francisco
Children's National Research Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
Pediatric Brain Tumor Consortium
University of Pittsburgh
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Augusta University
The University of Texas Health Science Center, Houston
Jazz Pharmaceuticals
University of Florida
Seattle Children's Hospital
Seattle Children's Hospital
M.D. Anderson Cancer Center
Cedars-Sinai Medical Center
Plus Therapeutics
Hackensack Meridian Health
Thomas Jefferson University